What is Edwards Lifesciences Corp worth?
With the base-case assumptions below, a discounted cash flow model on Edwards Lifesciences Corp's reported free cash flow gives $49.45 per share. The share price was $86.29 on September 25, 2026, 75% above that value.
Inputs from the filings
Three sets of assumptions
| Case | Growth yrs 1-5 | Discount rate | Value per share | Value vs price |
|---|---|---|---|---|
| Bear | 1.5% | 10.0% | $32.39 | -62% |
| Base | 6.5% | 9.0% | $49.45 | -43% |
| Bull | 11.5% | 8.0% | $83.47 | -3% |
Sensitivity: base case value per share
| 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | |
|---|---|---|---|---|---|
| 7.0% | $62.05 | $65.90 | $70.60 | $76.48 | $84.04 |
| 8.0% | $52.65 | $55.14 | $58.09 | $61.63 | $65.96 |
| 9.0% | $45.77 | $47.48 | $49.45 | $51.75 | $54.46 |
| 10.0% | $40.54 | $41.75 | $43.13 | $44.70 | $46.51 |
| 11.0% | $36.42 | $37.31 | $38.30 | $39.42 | $40.69 |
Where the presets come from
Base: years 1 to 5 grow at Edwards Lifesciences Corp's revenue growth rate over the last 5 fiscal years (6.7% a year), held between -5% and 15%. Years 6 to 10 grow halfway between that and the long-run rate of 2.5%. Future cash is discounted at 9% a year.
Bear: 5 points less growth, 2% long-run growth, 10% discount rate. Bull: 5 points more growth (at most 25%), 3% long-run growth, 8% discount rate.
Value per share = (present value of 10 years of free cash flow + present value of everything after + cash - debt) / diluted shares.
This is a model run on assumptions, not a recommendation or a price target. Small changes in the discount rate or growth move the result a lot, as the table above shows. Change them yourself in the calculator.
Adjust the assumptions
Move the sliders for growth, long-run growth and discount rate, or switch to average free cash flow, and see the value per share change.
Adjust the assumptions